Literature DB >> 17441051

Nucleophilic activation of alkenyl and aryl boronates by a chiral Cu(I)F complex: catalytic enantioselective alkenylation and arylation of aldehydes.

Daisuke Tomita1, Motomu Kanai, Masakatsu Shibasaki.   

Abstract

A new method for the catalytic enantioselective alkenylation and arylation of aldehydes involves the activation of alkenyl and aryl boronates by a catalytic amount of the Cu(I)F-DTBM-segphos complex through transmetalation, generating novel alkenyl and aryl copper species. These reagents act as the actual nucleophile. A range of aldehydes can be converted into optically active secondary allyl alcohols or diaryl methanols with excellent enantioselectivity. The appropriate choice of additives, depending on the substrate, is critical to ensure high yields of products. These additives possibly modulate the catalyst turnover step from copper alkoxide intermediates generated by the addition of organocopper reagents to aldehydes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17441051     DOI: 10.1002/asia.200600068

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  4 in total

1.  Rhodium(I)/diene-catalyzed addition reactions of arylborons with ketones.

Authors:  Yuan-Xi Liao; Chun-Hui Xing; Qiao-Sheng Hu
Journal:  Org Lett       Date:  2012-03-01       Impact factor: 6.005

2.  Aryl ketone synthesis via tandem orthoplatinated triarylphosphite-catalyzed addition reactions of arylboronic acids with aldehydes followed by oxidation.

Authors:  Yuan-Xi Liao; Qiao-Sheng Hu
Journal:  J Org Chem       Date:  2010-10-15       Impact factor: 4.354

3.  Ir(COD)Cl]2/Tris(2,4-di-t-butylphenyl)phosphite-Catalyzed Addition Reactions of Arylboronic Acids with Aldehydes.

Authors:  Yuan-Xi Liao; Jie Dong; Qiao-Sheng Hu
Journal:  Tetrahedron Lett       Date:  2018-03-02       Impact factor: 2.415

4.  Nucleophilic arylation with tetraarylphosphonium salts.

Authors:  Zuyong Deng; Jin-Hong Lin; Ji-Chang Xiao
Journal:  Nat Commun       Date:  2016-01-29       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.